PROTERIS BIOTECH, INC.
Glendale, CA · Biotech · Private
Recombinant clusterin (CLU) protein therapeutic delivered as eye drops to treat dry eye disease epitheliopathy
- Grants
- $896K
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Protection and Treatment of the Ocular Surface Barrier | $199,860 | |
| Federal grant | Department of Health and Human Services · Phase I · Protection and Treatment of the Ocular Surface Barrier | $80,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Clusterin Targeting of Ocular Surface Disease | $294,662 | |
| Federal grant | Department of Health and Human Services · Phase I · Clusterin Targeting Epitheliopathy for Dry Eye | $321,904 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3115 | METCURE THERAPEUTICS, LLC | — | — |
| 3116 | PAMDECA, LLC | — | — |
| 3117 | ALLYX BIOSCIENCES, INC. | — | — |
| 3118 | PROTERIS BIOTECH, INC. | — | — |
| 3119 | MEDITATI INC. | — | — |
| 3120 | BIOPICO SYSTEMS Inc. | — | — |
| 3121 | Appia Bio | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Promoting Ocular Nerve Regenerationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.